# Sickle Cell Disease

- Category: chronic
- Review status: reviewed (every claim checked against a document named on this page)
- Sources: ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class BD65.01 - condition scope only, no dose · No dose - referral pathway, no medicine given in primary care · Sickle Cell Disease - StatPearls - NCBI Bookshelf - https://www.ncbi.nlm.nih.gov/books/NBK482384/ · BSH Guideline on Management of Sickle Cell Disease 2018 · DROXIA (hydroxyurea) capsules US prescribing information, section 2.1 Dosage for Sickle Cell Anemia (DailyMed SetID a9494409-3571-4a81-9ad3-15ef7cb636a2) · Phenoxymethylpenicillin 250 mg Film-coated Tablets SmPC section 4.2 (eMC product 10628) · Sickle Cell Anemia - disease-level clinical article (sickle-cell-disease-referral-full.txt)
- Verified date: 2026-08

## Verified against

- No dose - referral pathway, no medicine given in primary care
- Sickle Cell Disease - disease-level clinical article (sickle-cell-disease-clinical.txt)
- BSH Guideline on Management of Sickle Cell Disease 2018
- DROXIA (hydroxyurea) capsules US prescribing information, section 2.1 Dosage for Sickle Cell Anemia (DailyMed SetID a9494409-3571-4a81-9ad3-15ef7cb636a2)
- Sickle Cell Anemia - disease-level clinical article (sickle-cell-disease-referral-full.txt)
- Sickle Cell Disease Primary Care Management & Referral - disease-level clinical article (sickle-cell-disease-referral-clinical.txt)
- Phenoxymethylpenicillin 250 mg Film-coated Tablets SmPC section 4.2 (eMC product 10628)

## Treatment metadata

- Folic acid — 5 mg — oral.solid
- Referral & safety-netting (no drug therapy)
- Hydroxyurea — 500 mg — oral.solid
- Phenoxymethyl penicillin — 250 mg — oral.solid

## Complete treatment card

```text
SICKLE CELL DISEASE
Sources: ICPC-3 (WONCA International Classification of Primary Care, 3rd edition) class BD65.01 -
         condition scope only, no dose · No dose - referral pathway, no medicine given in primary
         care · Sickle Cell Disease - StatPearls - NCBI Bookshelf -
         https://www.ncbi.nlm.nih.gov/books/NBK482384/ · BSH Guideline on Management of Sickle Cell
         Disease 2018 · DROXIA (hydroxyurea) capsules US prescribing information, section 2.1 Dosage
         for Sickle Cell Anemia (DailyMed SetID a9494409-3571-4a81-9ad3-15ef7cb636a2) ·
         Phenoxymethylpenicillin 250 mg Film-coated Tablets SmPC section 4.2 (eMC product 10628) ·
         Sickle Cell Anemia - disease-level clinical article (sickle-cell-disease-referral-full.txt)
Review status: REVIEWED against No dose - referral pathway, no medicine given in primary care,
               Sickle Cell Disease - disease-level clinical article (sickle-cell-
               disease-clinical.txt), BSH Guideline on Management of Sickle Cell
               Disease 2018, DROXIA (hydroxyurea) capsules US prescribing
               information, section 2.1 Dosage for Sickle Cell Anemia (DailyMed
               SetID a9494409-3571-4a81-9ad3-15ef7cb636a2), Sickle Cell Anemia -
               disease-level clinical article (sickle-cell-disease-referral-
               full.txt), Sickle Cell Disease Primary Care Management & Referral -
               disease-level clinical article (sickle-cell-disease-referral-
               clinical.txt), Phenoxymethylpenicillin 250 mg Film-coated Tablets
               SmPC section 4.2 (eMC product 10628)  (2026-08)

IS IT THIS? - reference only, to read alongside your own examination
  SYMPTOMS - what the patient reports (12)
    - Crises do not begin at birth, because fetal haemoglobin shields the infant until it fades over
      roughly 6-9 months
    - Everyone with the disease has vaso-occlusive crises, the earliest being dactylitis from six
      months of age
    - Presentation is by complication, acute or chronic, and vaso-occlusive crisis is the commonest
      acute one
    - Any organ can be hit, though limbs and chest lead; pain that sounds atypical means hunting
      another cause
    - Acute chest syndrome opens suddenly with cough and breathlessness; fever may be absent, and
      when present suggests infection  [breathlessness · cough]
    - Splenic sequestration: the spleen swells fast with left upper quadrant pain, commonest aged 1
      to 4 years
    - Children show acute anaemia and hypovolaemic shock, while in adults the onset is more
      insidious  [anaemia · shock]
    - Red flag: severe headache, altered mental state, slurred speech, fits or paralysis signal
      stroke  [headache · paralysis · seizures · slurred speech]
    - Aplastic crisis, usually from parvovirus B-19: severe fatigue, anaemia, breathlessness, even
      fainting  [anaemia · breathlessness · fatigue · syncope]
    - Acute intrahepatic cholestasis: sudden right upper quadrant pain, deepening jaundice, a big
      tender liver, pale stools  [abdominal pain · jaundice · pale stools · right upper quadrant
      pain]
    - Priapism means a painful unwanted erection going beyond 4 hours
    - Leg ulcers sit on the inner and outer ankle, and once deep to bone can bring osteomyelitis
  SIGNS - what you find (11)
    - Examine broadly to judge the need for oxygen, analgesia and transfusion
    - Red flag: a liver or spleen enlarging quickly points to a sequestration crisis
    - Orbital infarction shows proptosis, local pain, and swelling of lid or orbit  [ischaemia ·
      local tenderness · proptosis]
    - Eye movement is then reduced and visual acuity falls
    - Orbital compression syndrome brings ophthalmoplegia and sight loss from the orbital apex
      [loss of vision · ophthalmoplegia]
    - Hyphaema is blood in the anterior chamber after a blunt injury
    - Raised eye pressure is badly tolerated here and can end in retinal artery occlusion
    - Urine cannot be concentrated, so passing is frequent, dehydration likelier, and children may
      wet the bed  [dehydration]
    - Papillary necrosis shows as blood in the urine, more so in HbSC disease  [blood in the urine ·
      necrosis]
    - Avascular necrosis of the femoral head is a common source of lasting pain and disability
      [necrosis]
    - Pulmonary hypertension surfaces as breathlessness on exertion or swollen legs  [breathlessness
      · hypertension · leg swelling]
  TESTS (12)
    - Diagnosis is usually made in childhood, and newborn screening catches it at birth where such a
      programme runs
    - Other haemolytic conditions are excluded by history, examination, haemoglobin electrophoresis
      and the blood film
    - Creatinine rises late, so the first sign of kidney disease is microalbuminuria, 30 to 300 mg
      of albumin in a 24-hour collection; a spot urine-creatinine ratio is not a valid substitute
      here
    - Chest syndrome can begin during an admission for something else, so watch every inpatient for
      it
    - For chest syndrome send a blood count with differential, liver and kidney chemistry, blood and
      sputum cultures
    - A new infiltrate on the chest film is the defining feature of acute chest syndrome
    - Sequestration drops haemoglobin by more than 2gm/dL, with reticulocytosis and nucleated red
      cells
    - Hepatic sequestration is fast liver enlargement with haemoglobin down more than 2gm/dL;
      enzymes may stay normal
    - Transcranial Doppler and prevention cut childhood stroke; without them ~10% have overt stroke
      and 20 to 35% silent infarcts
    - A stroke needs urgent neurology input, a CT, and then MRI with MRA
    - In aplastic crisis the haemoglobin is very low and reticulocytes near absent
    - Cholestasis labs: very high bilirubin, raised alkaline phosphatase, deranged clotting;
      haemolysis markers may read normal
  IF NOT THIS - what else fits (12)
    - Haemoglobin S-beta-0 thalassaemia, which behaves just as HbSS does
    - Haemoglobin SC, milder, yet able to look like sickle cell anaemia
    - Haemoglobin S-beta+ thalassaemia, a milder variant again
    - Other haemoglobin variants can mimic it when co-inherited alongside HbS
    - Haemoglobin D-Punjab, O-Arab or E
    - Autoimmune haemolytic anaemia, warm or cold antibody
    - Alpha or beta thalassaemia
    - Paroxysmal nocturnal haemoglobinuria
    - Red cell membrane defects: hereditary spherocytosis or elliptocytosis
    - Enzyme defects: pyruvate kinase or glucose-6-phosphate deficiency
    - Drug-induced haemolysis, or a transfusion reaction, immediate or delayed
    - Microangiopathic haemolysis, or an infection such as malaria
  Source  StatPearls "Sickle Cell Anemia" - disease-level clinical article
  Status  traced to the source above

Rx: Main treatment  |  Pneumococcal prophylaxis

MAIN TREATMENT - choose one, plus any add-on marked below
1. FOLIC ACID                                             [1st line]
   Adult    5 mg once daily - long-term baseline support
   Peds     Under 1 year: 2.5 mg once daily
            1 year and over: 5 mg once daily
            (Children <1 year: 2.5 mg once daily; Children >=1 year: 5 mg once daily)
   Source   BSH Guideline on Management of Sickle Cell Disease 2018
   Why      Daily folic acid supports high erythroid turn-over in chronic haemolytic anaemia
   Caution  The preventive measures are penicillin V prophylaxis in children and
            pneumococcal/meningococcal vaccination.
            URGENT HOSPITAL ADMISSION: Admit for acute chest syndrome, fever >38.5C, severe vaso-
            occlusive pain unresponsive to oral analgesia, or a sudden drop in Hb
            (aplastic/sequestration crisis).
            This is SPECIALIST HAEMATOLOGY OVERSEEN CARE.
   Egypt    FOLIC ACID (EL NILE) 5 MG 50 TAB. EL NILE.                         26.25 EGP (0.53/unit)
            FOLIC ACID (MEMPHIS) 5 MG 30 TAB. MEMPHIS                          15.75 EGP (0.53/unit)
            FOLICINAD 5 MG 50 TABS.          INAD PHARMA         50.00 EGP (1.00/unit)
            FOLIC ACID (EIPICO) 5 MG 20 TAB. EIPICO              24.00 EGP (1.20/unit)
            FOLIC ACID (EL NILE) 5 MG 30 TAB. EL NILE.                         36.00 EGP (1.20/unit)
            FOLIRAQ 5000 MCG 30 CAPSULES     HP PHARMA           45.00 EGP (1.50/unit)
            FOLIDDOX 400 MCG / 5 ML LIQUID 150 ML MADDOX PHARMA                           150.00 EGP
                -> ? strength differs, ? different route - not oral solid

2. REFERRAL & SAFETY-NETTING (NO DRUG THERAPY)            [1st line]
   Adult    Inherited haemoglobin disorder causing vaso-occlusive pain crises and chronic
            haemolysis. GP supports with folic acid, infection-prevention advice and initial
            analgesia, but hydroxyurea initiation, transfusion decisions and crisis admission are
            haematologist-led.
   Source   Sickle Cell Anemia - disease-level clinical article (sickle-cell-disease-referral-
            full.txt)
   Why      Carries the referral criteria and warning signs for this condition, which apply
            whichever treatment is chosen.
   Caution  Refer a pain crisis that is not settling on simple analgesia - the ceiling of what
            primary care can do for a crisis is reached quickly.
            Sudden worsening pallor is an emergency in sickle cell disease and not a gradual anaemia
            to investigate at leisure.
            RED FLAG - Fever in an SCA patient requires prompt empiric antibiotics and urgent
            evaluation for sepsis; ill-appearing patients need admission and IV antibiotics.
            RED FLAG - Acute chest syndrome (sudden cough/dyspnea +/- fever) is a medical emergency
            requiring hospitalization regardless of SCA phenotype.
            RED FLAG - Stroke signs (severe headache, altered mental status, slurred speech,
            seizures, paralysis) require urgent neurological consultation and imaging.
            RED FLAG - Priapism lasting more than 4 hours needs early urologic involvement; delayed
            management can cause permanent impotence.
            RED FLAG - Splenic sequestration (rapid spleen enlargement with left-upper-quadrant
            pain, Hb drop >2g/dL) is a significant cause of acute, potentially life-threatening
            anemia, especially in young children.
            RED FLAG - Splenic sequestration crisis resulting in hypovolemic shock requires urgent
            aggressive management.

3. HYDROXYUREA                                            [add-on - not a substitute]
   Adult    15 mg/kg once daily, titrate by 5 mg/kg every 12 weeks to max 35 mg/kg daily under
            specialist supervision - long-term under haematologist care
   Peds     20 mg/kg/day  [child max 1500 mg]
            (20 mg/kg once daily under pediatric haematologist supervision;
            requires monthly FBC)
            3kg -> 60 mg/day    4kg -> 80 mg/day    5kg -> 100 mg/day   6kg -> 120 mg/day
            7kg -> 140 mg/day   8kg -> 160 mg/day   9kg -> 180 mg/day   10kg -> 200 mg/day
            11kg -> 220 mg/day  12kg -> 240 mg/day  13kg -> 260 mg/day  14kg -> 280 mg/day
            15kg -> 300 mg/day  16kg -> 320 mg/day  17kg -> 340 mg/day  18kg -> 360 mg/day
            19kg -> 380 mg/day  20kg -> 400 mg/day  21kg -> 420 mg/day  22kg -> 440 mg/day
            23kg -> 460 mg/day  24kg -> 480 mg/day  25kg -> 500 mg/day  26kg -> 520 mg/day
            27kg -> 540 mg/day  28kg -> 560 mg/day  29kg -> 580 mg/day  30kg -> 600 mg/day
            31kg -> 620 mg/day  32kg -> 640 mg/day  33kg -> 660 mg/day  34kg -> 680 mg/day
            35kg -> 700 mg/day  36kg -> 720 mg/day  37kg -> 740 mg/day  38kg -> 760 mg/day
            39kg -> 780 mg/day  40kg -> 800 mg/day  41kg -> 820 mg/day  42kg -> 840 mg/day
            43kg -> 860 mg/day  44kg -> 880 mg/day  45kg -> 900 mg/day  46kg -> 920 mg/day
            47kg -> 940 mg/day  48kg -> 960 mg/day  49kg -> 980 mg/day  50kg -> 1000 mg/day
   Source   DROXIA (hydroxyurea) capsules US prescribing information, section 2.1 Dosage for Sickle
            Cell Anemia (DailyMed SetID a9494409-3571-4a81-9ad3-15ef7cb636a2)
   Why      Disease-modifying therapy: increases HbF levels, reduces vaso-occlusive pain crises and
            acute chest syndrome
   Caution  Causes bone marrow suppression: monitor FBC every 4 weeks.
            Teratogenic: contraception required during treatment and for 6 months after stopping.
            Hydroxyurea is SPECIALIST HAEMATOLOGIST PRESCRIBED ONLY.
   Egypt    CYTODROX 500 MG 100 CAPS.        CIPLA LTD. - ...   588.00 EGP (5.88/unit)
            HYDREA 500 MG 20 CAPS.           BRISTOL-MYERS...   230.00 EGP (11.50/unit)
            HYDROXYUREA-MEDAC 500 MG 100 CAPS. SS MEDAC > EGYPTIAN PHAR...  2250.00 EGP (22.50/unit)


PNEUMOCOCCAL PROPHYLAXIS - give alongside
4. PHENOXYMETHYL PENICILLIN                               [add-on - not a substitute]
   Adult    500 mg every 12 hours - Long-term - the disease article describes it as lifelong
   Peds     The label's dosing table for pneumococcal prophylaxis (section 4.2) - which covers
            asplenia and sickle cell disease - gives adults and children over 12 years 500 mg every
            12 hours, children 6 to 12 years 250 mg every 12 hours, and children under 5 years 125
            mg every 12 hours. It leaves no separate band for age 5 to 6, jumping straight from
            under-5 to 6-12, and it adds that tablets are not usually given under 5 years or to a
            child who cannot swallow them - use the oral suspension there instead.
   Source   Phenoxymethylpenicillin 250 mg Film-coated Tablets SmPC section 4.2 (eMC product 10628)
   Why      A5 chunk 5 refused this because MSF states the indication and attaches no prophylactic
            dose - its dose table is for streptococcal pharyngitis, scarlet fever and diphtheria,
            and borrowing that would have been inventing a regimen. The dose was hunted instead. The
            Egyptian formulary's phenoxymethylpenicillin monograph has no sickle-cell entry either,
            so a UK label was fetched and cached: the Phenoxymethylpenicillin 250 mg Film-coated
            Tablets SmPC carries "Prophylaxis of pneumococcal infection (e.g. in asplenia and in
            patients with sickle cell disease)." in section 4.1 and the prophylactic regimen in
            section 4.2. The indication is also in this card's own article - "Besides lifelong
            administration of penicillin V, vaccinations against meningococcus, pneumococcus, and
            hemophilus influenza B are available to prevent infection with encapsulated organisms."
   Caution  CONTRAINDICATED, per section 4.3 of the label: phenoxymethylpenicillin is not for the
            patient known to be hypersensitive to penicillin or to any excipient in the product, and
            it is used cautiously in anyone with a history of allergy. Attention should be paid to
            possible cross-sensitivity with other beta-lactams such as cephalosporins.
            This is prophylaxis, not treatment. The label adds that severe acute infections should
            not be treated with phenoxymethylpenicillin - a febrile sickle-cell patient needs
            assessment and parenteral cover, not this tablet.
            MSF names the indication and gives no dose for it - it lists phenoxymethylpenicillin as
            one given to children to head off pneumococcal infection in sickle cell disease, and to
            stop acute rheumatic fever returning. The dose here is the UK label's, not MSF's, and
            not the pharyngitis dose.
            Egyptian products are sold in international units - OSPEN 1.0 MIU and 1.5 MIU tablets.
            The label's own conversion puts phenoxymethylpenicillin 250 mg at roughly 400,000 units,
            so 500 mg is about 800,000 units.
            Take at least 30 minutes before or 2 hours after food; food reduces absorption.
            Prophylaxis does not replace pneumococcal, meningococcal and Hib vaccination - the
            article names them in the same sentence.
   Egypt    OSPEN 1.0 MIU 12 F.C.TABS.       SANDOZ              24.00 EGP (2.00/unit)
                -> ? strength differs
            OSPEN 1.5 MIU 12 F.C.TABS.       SANDOZ              41.00 EGP (3.42/unit)
                -> ? strength differs

Prices are indicative (dataset snapshot 2026-06); verify with the pharmacy.
```

---

Dawaa Reference is a reference for prescribers, not a medical device, and does not replace clinical judgement.

[Privacy policy](/privacy)
